News
globenewswire.comConexeu Expands Board, Executive, and Advisory Leadership With Five Appointments Post Nasdaq Listingglobenewswire.comJun 15
globenewswire.comConexeu Sciences Reports Manufacturing Scale Up and Regulatory Progress for Lead CXU™ Wound Care Programglobenewswire.comJun 8
globenewswire.comConexeu Sciences to Ring Nasdaq Bell on June 10, 2026globenewswire.comJun 3
globenewswire.comUPDATE - Conexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicineglobenewswire.comMay 27
globenewswire.comConexeu Sciences Initiates Preclinical Development Program for B.R.E.A.S.T.™ Bioregenerative Matrix Platform with Wake Forest Institute for Regenerative Medicineglobenewswire.comMay 27